Price
Financials
Standalone, Rs crore| Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.94 | 12.87 | 11.80 | 11.70 | 12.33 | 1.18 | 0.58 | 0.00 | 0.00 | 0.00 |
| Expenses | 13.18 | 11.61 | 10.03 | 9.44 | 9.62 | 4.20 | 4.39 | 0.35 | 0.60 | 0.40 |
| Operating Profit | 6.76 | 1.26 | 1.77 | 2.26 | 2.71 | -3.02 | -3.81 | -0.35 | -0.60 | -0.40 |
| OPM % | 33.90% | 9.79% | 15.00% | 19.32% | 21.98% | -255.93% | -656.90% | |||
| Other Income | 0.07 | 0.16 | 0.07 | 0.17 | 0.02 | 0.04 | 5.69 | -0.67 | 0.01 | 0.00 |
| Interest | 0.09 | 1.31 | 0.20 | 0.20 | 0.41 | 0.36 | 0.28 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.58 | 0.57 | 0.58 | 0.59 | 0.61 | 0.64 | 0.48 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 6.16 | -0.46 | 1.06 | 1.64 | 1.71 | -3.98 | 1.12 | -1.02 | -0.59 | -0.40 |
| Tax % | 0.00% | -78.26% | 29.25% | 35.37% | 39.77% | -19.10% | -11.61% | 2.94% | 123.73% | 0.00% |
| Net Profit | 6.17 | -0.10 | 0.76 | 1.07 | 1.03 | -3.22 | 1.24 | -1.04 | -1.32 | -0.40 |
| EPS in Rs | 8.81 | -0.14 | 0.72 | 1.02 | 0.98 | -3.07 | 1.18 | -0.99 | -1.26 | -0.38 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 33.44 | 33.32 | 32.70 | 32.44 | 23.38 | 13.46 | 0.31 | 0.00 |
| Expenses | 26.61 | 29.88 | 27.26 | 24.14 | 19.30 | 13.68 | 4.45 | 1.00 |
| Operating Profit | 6.83 | 3.44 | 5.44 | 8.30 | 4.08 | -0.22 | -4.14 | -1.00 |
| OPM % | 20.42% | 10.32% | 16.64% | 25.59% | 17.45% | -1.63% | -1,335.48% | |
| Other Income | 0.08 | 0.03 | 0.06 | 0.17 | 0.24 | 0.00 | 5.02 | 0.01 |
| Interest | 2.07 | 2.41 | 2.44 | 1.62 | 0.45 | 0.80 | 0.30 | 0.00 |
| Depreciation | 2.15 | 2.13 | 1.31 | 1.14 | 1.17 | 1.25 | 0.48 | 0.00 |
| Profit before tax | 2.69 | -1.07 | 1.75 | 5.71 | 2.70 | -2.27 | 0.10 | -0.99 |
| Tax % | 49.07% | -18.69% | -16.57% | 37.30% | 32.59% | -3.52% | -100.00% | 73.74% |
| Net Profit | 1.36 | -0.86 | 2.05 | 3.57 | 1.83 | -2.19 | 0.20 | -1.72 |
| EPS in Rs | 1.94 | -1.23 | 2.93 | 5.10 | 1.74 | -2.09 | 0.19 | -1.64 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | -100% | ||
| Compounded Profit Growth | % | % | % | 63% | ||
| Stock Price CAGR | % | % | -32% | -44% | ||
| Return on Equity | % | -2% | -9% | -7% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 7.00 | 7.00 | 7.00 | 10.50 | 10.50 | 10.50 | 10.50 |
| Reserves | 5.35 | 4.49 | 6.68 | 9.96 | 53.79 | 15.43 | 16.29 | 13.25 |
| Borrowings | 27.18 | 23.51 | 17.04 | 8.69 | 9.29 | 12.74 | 0.00 | 0.00 |
| Other Liabilities | 3.77 | 6.92 | 6.06 | 8.33 | 2.36 | 3.07 | 0.06 | 0.01 |
| Total Liabilities | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
| Fixed Assets | 20.17 | 18.72 | 17.46 | 16.71 | 16.52 | 17.27 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | 0.00 | 0.00 | 0.00 |
| Investments | 0.10 | 0.10 | 0.47 | 0.10 | 0.10 | 0.03 | 0.03 | 0.00 |
| Other Assets | 23.03 | 23.10 | 18.85 | 17.17 | 58.29 | 24.44 | 26.82 | 23.76 |
| Total Assets | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 5.40 | 3.90 | 6.88 | 9.42 | -40.42 | -5.07 | 12.32 | -4.51 |
| Cash from Investing Activity | -0.33 | -0.04 | 0.02 | 0.01 | -1.90 | -0.82 | 21.80 | 0.04 |
| Cash from Financing Activity | -4.77 | -3.05 | -7.22 | -9.66 | 45.70 | 2.67 | -13.01 | 0.00 |
| Net Cash Flow | 0.31 | 0.81 | -0.33 | -0.22 | 3.38 | -3.22 | 21.11 | -4.47 |
| Free Cash Flow | 5.00 | 3.79 | 6.84 | 8.96 | -42.42 | -6.10 | 33.42 | -4.51 |
| CFO/OP | 79% | 113% | 126% | 105% | -960% | 2,259% | -304% | 401% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94.85 | 68.68 | 87.51 | 100.25 | 151.43 | 52.88 | 376.77 | |
| Inventory Days | 169.49 | 157.97 | 34.46 | 88.98 | 69.12 | 131.64 | 0.00 | |
| Days Payable | 229.91 | 391.69 | 138.68 | 432.74 | 110.43 | 765.90 | ||
| Cash Conversion Cycle | 34.44 | -165.03 | -16.71 | -243.52 | 110.13 | -581.38 | 376.77 | |
| Working Capital Days | 19.21 | 12.16 | 7.14 | -29.70 | 344.86 | -238.36 | 1,283.39 | |
| ROCE % | 3.81% | 12.75% | 26.22% | 6.35% | -2.51% | -13.69% | -3.92% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.29% | 54.29% | 54.29% | 54.29% | 54.29% | 54.29% | 54.29% | 54.90% | 55.10% | 35.44% | 22.88% | 22.88% |
| Public | 45.72% | 45.71% | 45.71% | 45.72% | 45.73% | 45.72% | 45.70% | 45.10% | 44.91% | 64.56% | 77.11% | 77.12% |
| No. of Shareholders | 880 | 935 | 947 | 1,010 | 974 | 989 | 938 | 917 | 915 | 985 | 1,149 | 1,133 |
Fundamentals
Market Cap₹ 14.0 Cr.
Current Price₹ 13.4
Book Value₹ 22.6
ROCE-3.92 %
ROE-6.81 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-100%
Compounded Profit Growth (TTM)63%
Standalone figures.
Valuation
Market capRs 13 Cr
Enterprise valueRs 25 Cr
Price to book0.49x
Price to sales0.95x
EV / sales1.87x
Earnings yield-17.17%
P/E, 3-year average25.69x
P/B, 3-year average1.16x
P/E, 5-year average25.69x
P/B, 5-year average1.16x
Profitability
Operating margin (excl. other income)-1.63%
Operating margin (incl. other income)-1.63%
EBITDA margin-1.63%
Pre-tax margin-16.86%
Net profit margin-16.27%
ROE-4.85%
ROCE-2.62%
ROA-3.72%
ROE, 3-year average7.65%
ROCE, 3-year average9.91%
ROA, 3-year average3.23%
ROE, 5-year average6.41%
ROCE, 5-year average9.22%
ROA, 5-year average2.58%
ROIC (approx.)-3.70%
Tax rate3.52%
Growth
Sales growth (latest year)-42.43%
Profit growth (latest year)-219.67%
Sales CAGR, 3 years-25.61%
Sales CAGR, 5 years-16.64%
Per share
EPS (TTM)Rs -2.09
EPS (latest year)Rs -2.09
EPS, 3-year averageRs 1.59
EPS, 5-year averageRs 1.29
Book value per shareRs 24.70
Sales per shareRs 12.82
Cash flow per shareRs -4.83
Free cash flow per shareRs -4.30
Efficiency
Asset turnover0.32x
Fixed asset turnover0.78x
Inventory turnover20.64x
Inventory days18 days
Debtor days53 days
Debtors turnover6.90x
Creditor days766 days
Cash conversion cycle377 days
Working capital days1283 days
Leverage
Total debtRs 13 Cr
Cash and bankRs 0 Cr
Net debtRs 12 Cr
Debt to equity0.49x
Interest coverage-1.84x
Owners' fund to total sources62.12%
Debt to assets30.52%
Cash flow
Cash from Operating Activity (latest year)Rs -5 Cr
Cash from Investing Activity (latest year)Rs -1 Cr
Cash from Financing Activity (latest year)Rs 3 Cr
Net Cash Flow (latest year)Rs -3 Cr
Free cash flow (latest year)Rs -5 Cr
FCFE (approx.: FCF + change in debt)Rs -1 Cr
Cash from ops / profit, 5 years-16.72x
Statement figures
Net sales (TTM)Rs 13 Cr
Net sales (latest year)Rs 13 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -2 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs -2 Cr
Net profit (latest year)Rs -2 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 9 Cr
Total expenditure (latest year)Rs 14 Cr
Total income (latest year)Rs 13 Cr
Share capitalRs 10 Cr
ReservesRs 15 Cr
Shareholders' fundsRs 26 Cr
Total assetsRs 42 Cr
Net blockRs 17 Cr
InvestmentsRs 0 Cr
ReceivablesRs 2 Cr
InventoryRs 0 Cr
Other liabilitiesRs 3 Cr
Shares outstanding (crore)1.05
Ownership
Promoter holding22.88% (-32.02 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.49 is at the 28th percentile (median 2.09).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 543520 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -13.9% | -2.8% | -11.1 pts |
| 1 month | +15.4% | -6.8% | +22.2 pts |
| 3 months | +2.7% | -7.6% | +10.3 pts |
| 3 years | -72.1% | +14.2% | -86.3 pts |
Red flags
F-score 2 of 8| explain | Weak cash conversion Cash from operations was -1124% of net profit over the last 3 years |
| explain | Debt up, profit down Borrowings up 37% while net profit fell in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹0 Cr -100.0% vs Mar 2024.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd (543520) has a market capitalisation of Rs 14.0 Cr. at the 2026-10-01 close.
What were Global Longlife Hospital and Research Ltd's latest quarterly results?
In the Mar 2026 quarter, Global Longlife Hospital and Research Ltd sales was Rs 0 Cr (-100.0% vs Mar 2024) with a net loss of Rs 0 Cr.